Literature DB >> 21328057

Painful myositis in the anti-synthetase syndrome with anti-PL12 antibodies.

Puja Mehta, Leena Patel, Federico Roncaroli, Matthew C Pickering, Alexander Brand.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21328057     DOI: 10.1007/s00296-011-1811-4

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


× No keyword cloud information.
  6 in total

1.  Re-classifying myositis.

Authors:  Shabina M Sultan; David A Isenberg
Journal:  Rheumatology (Oxford)       Date:  2009-12-29       Impact factor: 7.580

2.  Clinical manifestations of anti-synthetase syndrome positive for anti-alanyl-tRNA synthetase (anti-PL12) antibodies: a retrospective study of 17 cases.

Authors:  Baptiste Hervier; Benoit Wallaert; Eric Hachulla; Daniel Adoue; Dominique Lauque; Marie Audrain; Boubou Camara; Bernard Fournie; Bertrand Couret; Pierre-Yves Hatron; Sylvain Dubucquoi; Mohamed Hamidou
Journal:  Rheumatology (Oxford)       Date:  2010-02-15       Impact factor: 7.580

3.  Clinical manifestations in patients with antibody to PL-12 antigen (alanyl-tRNA synthetase).

Authors:  I N Targoff; F C Arnett
Journal:  Am J Med       Date:  1990-03       Impact factor: 4.965

4.  Clinical heterogeneity and prognostic features of South Australian patients with anti-synthetase autoantibodies.

Authors:  M Dugar; S Cox; V Limaye; P Blumbergs; P J Roberts-Thomson
Journal:  Intern Med J       Date:  2010-01-04       Impact factor: 2.048

Review 5.  Clinical profile of anti-PL-12 autoantibody. Cohort study and review of the literature.

Authors:  Meena Kalluri; Steven A Sahn; Chester V Oddis; Suzanne L Gharib; Lisa Christopher-Stine; Sonye K Danoff; Livia Casciola-Rosen; Grace Hong; Paul F Dellaripa; Kristin B Highland
Journal:  Chest       Date:  2009-02-18       Impact factor: 9.410

Review 6.  Myositis-specific autoantibodies: their clinical and pathogenic significance in disease expression.

Authors:  Harsha Gunawardena; Zoe E Betteridge; Neil J McHugh
Journal:  Rheumatology (Oxford)       Date:  2009-06       Impact factor: 7.580

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.